» Articles » PMID: 15293351

Insights into the Mechanism of Magnetofection Using PEI-based Magnetofectins for Gene Transfer

Overview
Journal J Gene Med
Date 2004 Aug 5
PMID 15293351
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Gene delivery by the use of magnetic forces, so-called magnetofection, has been shown to enhance transfection efficiency of viral and non-viral systems up to several-hundred-fold. For this purpose gene carriers, such as polyethylenimine (PEI), are associated with superparamagnetic nanoparticles and complexed with plasmid DNA. Gene delivery is targeted by the application of a magnetic field.

Methods: To investigate the underlying mechanism, we studied the impact of the applied magnetic field on the transfection process of PEI-coated superparamagnetic iron oxide gene vectors (magnetofectins) using various cell lines. In particular, we addressed the question whether accelerated sedimentation of magnetofectins is the driving force or if the magnetic field itself directly influences the endocytic processing of the magnetofectins. The cellular uptake mechanism of magnetofectins was studied by electron microscopy and transfection experiments in the presence of various inhibitors that operate at different steps of endocytosis.

Results: In this study we could show that cellular uptake of magnetofectins proceeds obviously by endocytosis. Cellular uptake of magnetofectins behaves almost analogously as compared with PEI polyplexes. Besides unspecific endocytosis, apparently clathrin-dependent as well as caveolae-mediated endocytic uptake is involved.

Conclusions: The magnetic field itself does not alter the uptake mechanism of magnetofectins. Obviously, the magnetic forces lead to an accelerated sedimentation of magnetofectins on the cell surface and do not directly affect the endocytic uptake mechanism. So further improvement of magnetic field application could lead to efficient targeting of gene expression into the desired organ and tissue in vivo.

Citing Articles

Combination of magnetic hyperthermia and gene therapy for breast cancer.

Solak K, Yildiz Arslan S, Acar M, Turhan F, Unver Y, Mavi A Apoptosis. 2024; 30(1-2):99-116.

PMID: 39427089 DOI: 10.1007/s10495-024-02026-4.


Application of Nanoparticles for Magnetic Hyperthermia for Cancer Treatment-The Current State of Knowledge.

Szwed M, Marczak A Cancers (Basel). 2024; 16(6).

PMID: 38539491 PMC: 10969623. DOI: 10.3390/cancers16061156.


Modified core-shell magnetic mesoporous zirconia nanoparticles formed through a facile "outside-to-inside" way for CT/MRI dual-modal imaging and magnetic targeting cancer chemotherapy.

Chen L, Zhong H, Qi X, Shao H, Xu K RSC Adv. 2022; 9(23):13220-13233.

PMID: 35520762 PMC: 9063760. DOI: 10.1039/c9ra01063g.


Rapidly Transducing and Spatially Localized Magnetofection Using Peptide-Mediated Non-Viral Gene Delivery Based on Iron Oxide Nanoparticles.

Ferreras L, Chan S, Vazquez Reina S, Dixon J ACS Appl Nano Mater. 2021; 4(1):167-181.

PMID: 33763629 PMC: 7978400. DOI: 10.1021/acsanm.0c02465.


Poly[oligo(ethylene glycol) methacrylate]--poly[(vinyl benzyl trimethylammonium chloride)] Based Multifunctional Hybrid Nanostructures Encapsulating Magnetic Nanoparticles and DNA.

Chroni A, Forys A, Trzebicka B, Alemayehu A, Tyrpekl V, Pispas S Polymers (Basel). 2020; 12(6).

PMID: 32503350 PMC: 7362237. DOI: 10.3390/polym12061283.